[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Matthew J. Shattock, a director of Clorox Co. (CLX), reported two grants of Deferred Stock Units (DSUs) that increase his notional holdings. On 08/29/2025 he received 172.9087 DSUs through dividend reinvestment, and on 09/30/2025 he received 415.6529 DSUs in lieu of quarterly director fees.

The report shows DSUs convert on a 1-for-1 basis into common stock at the director's retirement or termination and that the total DSUs after the September grant equal 17,070.6618 shares. Both grants are reported as direct beneficial ownership and have a $0.00 per-unit price because they are deferred compensation awards.

Positive

• Director increased holdings by 415.6529 DSUs on 09/30/2025, raising total to 17,070.6618
• DSUs convert 1-for-1 into common stock at retirement/termination, providing clear settlement terms

Negative

• None.

Insights

Corporate Governance Analyst

Director accepted deferred stock compensation, boosting direct holdings to 17,070.6618 DSUs.

The filings confirm two separate DSU credits: 172.9087 on 08/29/2025 and 415.6529 on 09/30/2025. These were recorded as direct ownership and reflect standard independent director deferred-compensation mechanics.

The DSUs are settled 1-for-1 into Clorox common stock upon retirement or termination, which means the reported units represent a future equity payout rather than immediate stock transfers.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Shattock Matthew J

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	08/29/2025		A(2)	V	172.9087		(3)	(3)	Common Stock	172.9087	$0.0000	16,655.0089	D
Deferred Stock Units	(1)	09/30/2025		A(4)		415.6529		(3)	(3)	Common Stock	415.6529	$0.0000	17,070.6618	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CLX director Matthew J. Shattock receive?

He received 172.9087 DSUs on 08/29/2025 and 415.6529 DSUs on 09/30/2025.

How many DSUs does Matthew J. Shattock own after the reported transactions?

The report shows a total of 17,070.6618 DSUs following the 09/30/2025 grant.

How and when will the DSUs be settled?

The DSUs will be settled 100% in Clorox stock on a 1-for-1 basis upon the reporting person's retirement or termination.

Were any cash payments made for these DSUs?

No; the filing lists a per-unit price of $0.00, indicating these are deferred compensation awards, not purchases.

What was the reason for the 09/30/2025 DSU grant?

The filing states the 09/30/2025 DSUs were received in lieu of quarterly director's fees.